# Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers

> **NCT00687232** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 30 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD4818
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00687232
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00687232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00687232, "Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00687232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*